Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lluch

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Cancers|February 14, 2020
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young WomenSara S Oltra, Juan Miguel Cejalvo, Eduardo Tormo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Quality Indicators to Assure and Improve Cancer Care in Spain Using the Delphi TechniqueCarlos Camps, Joan Albanell, Antonio Antón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 25, 2022
The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic reviewJuan C Vázquez, Antonio Piñero, Francisco J de Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupMichel Marty, Francesco Cognetti, Dominique Maraninchi, et al.
Molecular Cancer Therapeutics|September 8, 2016
c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast CancerRaúl Rincón, Sandra Zazo, Cristina Chamizo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2012
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysisMaider Ibarrola-Villava, Hui-Han Hu, Mickaël Guedj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancerEva Thomas, Josep Tabernero, Monica Fornier, et al.
Cell Death Discovery|August 22, 2024
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancerSandra Torres-Ruiz, Iris Garrido-Cano, Ana Lameirinhas, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2014
Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancerJetzabel García-Parra, Alba Dalmases, Beatriz Morancho, et al.
Breast Cancer Research and Treatment|January 12, 2010
Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo RegisterJavier Puente, Sara López-Tarruella, Amparo Ruiz, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Cancers|February 14, 2020
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young WomenSara S Oltra, Juan Miguel Cejalvo, Eduardo Tormo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Quality Indicators to Assure and Improve Cancer Care in Spain Using the Delphi TechniqueCarlos Camps, Joan Albanell, Antonio Antón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 25, 2022
The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic reviewJuan C Vázquez, Antonio Piñero, Francisco J de Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupMichel Marty, Francesco Cognetti, Dominique Maraninchi, et al.
Molecular Cancer Therapeutics|September 8, 2016
c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast CancerRaúl Rincón, Sandra Zazo, Cristina Chamizo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2012
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysisMaider Ibarrola-Villava, Hui-Han Hu, Mickaël Guedj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancerEva Thomas, Josep Tabernero, Monica Fornier, et al.
Cell Death Discovery|August 22, 2024
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancerSandra Torres-Ruiz, Iris Garrido-Cano, Ana Lameirinhas, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2014
Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancerJetzabel García-Parra, Alba Dalmases, Beatriz Morancho, et al.
Breast Cancer Research and Treatment|January 12, 2010
Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo RegisterJavier Puente, Sara López-Tarruella, Amparo Ruiz, et al.
Pageof 19